GCM
TMDX icon

Graham Capital Management’s Transmedics TMDX Stock Holding History

Graham Capital Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,814
Closed -$280K – 1508
2026
Q1 		$280K Sell
2,814
-4,971
-64% -$648K 0.01% 842
2025
Q4 		$947K Sell
7,785
-270
-3% -$33.9K 0.02% 405
2025
Q3 		$904K Sell
8,055
-12,558
-61% -$1.47M 0.01% 415
2025
Q2 		$2.76M Sell
20,613
-9,957
-33% -$1.09M 0.04% 270
2025
Q1 		$2.06M Sell
30,570
-386
-1% -$26.5K 0.04% 319
2024
Q4 		$1.93M Buy
30,956
+26,596
+610% +$2.48M 0.03% 300
2024
Q3 		$685K Buy
+4,360
New +$672K 0.01% 558
2024
Q2 		– Sell
-40,454
Closed -$2.99M – 1365
2024
Q1 		$2.99M Buy
+40,454
New +$3.33M 0.06% 184

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Graham Capital Management's TMDX Position: Q2 2026 in Review

Graham Capital Management sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 2,814 shares — an estimated $280K sold.

Graham Capital Management first reported a position in TMDX in Q1 2024 and held it in 8 quarters. The position peaked at $2.99M in Q1 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Graham Capital Management reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Graham Capital Management sold 2,814 Transmedics shares in Q2 2026, an estimated $280K.
  • Graham Capital Management first reported a position in Transmedics in Q1 2024 and held it in 8 quarters.
  • Graham Capital Management's Transmedics position peaked at $2.99M in Q1 2024.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.